EU Research & Innovation
Programme Opportunities

ERA for Health

___________

Snapshot overview: Partnership to improve flexible joint programming with specific focus on research funders

___________

Name: ERA 4 Health

___________

Institution/ DG/ Agency responsible at EU-level:  European Research Council

___________

Work programme: 2022-2028

___________

Programme: Grants, others TBD

___________

Programme budget: TBD

___________

Project budget: TBD

___________

Type of funding : TBD

___________

Target participants: This Partnership  aims to include smaller EU research funders. .  It will be open to public funders at both national and regional level in the EU and those from Associated Countries to Horizon Europe as well as  public funders from third countries. . The focus is ensuring commitment, and cooperation on ongoing, emerging or novel opportunities for the advancement of clinical research and biomedical innovation.

Other funders that could get involved in specific co-funding activities are:

  • Private foundations and philanthropy organisations
  • Pharmaceutical, diagnostic, biotech and ICT industry

___________

Programme scope: Flexible

___________

Participant criteria: Financial contribution from health research funders required for joint transnational calls for proposals. The potential and commitments for sharing “own” intra-mural research has to be explored, but would not be a priority.

___________

Project duration: TBD

___________

Average time from submission to project kick-off: TBD

___________

R&D stage: Any

___________

Intellectual property: TBD

___________

Project database: TBD

___________

Status: Draft, start foreseen by end of 2022

___________

Contact details & more information: